You are here:

Home
NICE Guidance
Conditions and diseases
Cancer
Metastases

Sunitinib for the first-line treatment of advanced and/or metastatic renal cell carcinoma

Technology appraisal guidance
Reference number: TA169
Published: 25 March 2009

Guidance
Tools and resources
Information for the public
Evidence
History

Rarer Cancers Forum and Macmillan Cancer Support

Rarer Cancers Forum and Macmillan Cancer Support: appeals received
Rarer Cancers Forum and Macmillan Cancer Support: initial scrutiny letter
Rarer Cancers Forum and Macmillan Cancer Support: response to scrutiny letter
Rarer Cancers Forum and Macmillan Cancer Support: final scrutiny letter

This page was last updated: 30 March 2010